CLINICAL_TRIALS trial_result · 2017-03-20

Clinical Trial Update: A Study of LY2405319 in Participants With Type 2 Diabetes [Phase 1]

Phase 1 study of Eli Lilly's LY2405319 in participants with Type 2 diabetes has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2017-03-20